Miscarriage, also called spontaneous abortion, is the loss of pregnancy prior to the twentieth week of gestation. Such losses occur in about 15% of pregnancies, and the risk of miscarriage increases proportionately to the number of previous miscarriages a woman experienced. Furthermore, doctors have become increasingly aware of an association between infertility and repetitive miscarriages.
The Creighton Model FertilityCare™ System and NaProTECHNOLOGY® can identify women who are at risk for miscarriage even before any miscarriage occurs. Daily observation and charting of a woman’s natural biomarkers can reveal conditions that might lead to a miscarriage if pregnancy occurs. Using the NaProTECHNOLOGY® approach to address this problem, a detailed study of the woman's FertilityCare™ chart is performed followed by an accurately timed hormone analysis of her cycle. Treatment is then directed toward correcting abnormalities prior to conception, which reduces the risk of miscarriage.